P859: ANTI-CD38 NANOBODY JK36 ALLOWS RELIABLE MRD DETECTION IN DARATUMUMAB TREATED MULTIPLE MYELOMA PATIENTS
Main Authors: | E. Meseguer Martinez, J. Marco Buades, A. García Feria, P. Ribas García, M. J. Fernandez Llavador, A. López Gabaldon, S. Broseta Tormos, E. Francés Aracil, O. Cortés Ortega, E. Donato Martínez, M. Fernandez Zarzoso, M. Panero Ruiz, M. J. Cejalvo Andújar, A. Tolosa Muñoz, M. L. Juan Marco, D. Ivars Santacreu, E. Gómez Beltrán, M. J. Sayas Lloris |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000846316.26911.4d |
Similar Items
-
P1527: NEXT GENERATION SEQUENCING IN HEREDITARY SPHEROCYTOSIS DIAGNOSIS
by: A. García Feria, et al.
Published: (2022-06-01) -
The JK System to Detect Plagiarism
by: Khair Eddin M. Sabri, et al.
Published: (2006-10-01) -
PHOTOMETRICAL STUDY OF OVERCONTACT BINARY SYSTEM V859Cyg
by: E. A. Panko, et al.
Published: (2016-10-01) -
P889: WILL OUTCOME IMPROVE BY TREATING MULTIPLE MYELOMA PATIENTS AT MRD RELAPSE? THE REMNANT STUDY (RELAPSE FROM MRD NEGATIVITY AS INDICATION FOR TREATMENT)
by: F. B. Askeland, et al.
Published: (2022-06-01) -
MRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma
by: Manisha Bhutani, et al.
Published: (2025-02-01)